Publicaciones (43) Publicaciones en las que ha participado algún/a investigador/a

2017

  1. Accuracy of the Ultra-Rapid Urease Test for diagnosis of Helicobacter pylori infection

    Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 651-657

  2. Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance

    World Journal of Gastroenterology, Vol. 23, Núm. 18, pp. 3367-3373

  3. Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment

    Digestive Diseases, Vol. 35, Núm. 3, pp. 275-281

  4. Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages

    Journal of Hepatology, Vol. 66, Núm. 1, pp. 102-115

  5. Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

    Inflammatory Bowel Diseases, Vol. 23, Núm. 8, pp. 1394-1402

  6. Colitis quística profunda: informe de 2 casos con 15 años de seguimiento

    Gastroenterologia y Hepatologia, Vol. 40, Núm. 6, pp. 406-408

  7. Colorectal and interval cancers of the Colorectal Cancer Screening Program in the Basque Country (Spain)

    World Journal of Gastroenterology, Vol. 23, Núm. 15, pp. 2731-2742

  8. Consumo de cannabis e invaginaciones intestinales. ¿Una asociación casual?

    Revista Espanola de Enfermedades Digestivas, Vol. 109, Núm. 2, pp. 157-159

  9. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs

    United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260

  10. Dealing with pancreatic cancer in two different ways

    Clinica Chimica Acta

  11. Dysmetabolic iron overload syndrome: The need for an accurate liver iron concentration determination by magnetic resonance imaging

    Hepatology

  12. Early tuberculin skin test for the diagnosis of latent tuberculosis infection in patients with inflammatory Bowel disease

    Journal of Crohn's and Colitis, Vol. 11, Núm. 7, pp. 792-800

  13. Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients

    Journal of Gastroenterology, Vol. 52, Núm. 7, pp. 788-799

  14. Enfermedad inflamatoria intestinal como efecto paradójico del tratamiento con anti-TNF-α

    Gastroenterologia y Hepatologia

  15. Erratum to “IV Spanish Consensus Conference on Helicobacter pylori infection treatment” <(Gastroenterol Hepatol (2016) 39 (697–721)> (Gastroenterologia y Hepatologia (S0210570516300589) (10.1016/j.gastrohep.2016.05.003))

    Gastroenterologia y Hepatologia

  16. Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients (J Gastroenterol, 10.1007/s00535-016-1274-1)

    Journal of Gastroenterology

  17. Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

    American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131

  18. Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry

    American Journal of Gastroenterology, Vol. 112, Núm. 7, pp. 1135-1143

  19. Granulocyte-Monocyte Apheresis as an Adjuvant Therapy to Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis

    Therapeutic Apheresis and Dialysis, Vol. 21, Núm. 1, pp. 26-30

  20. Hepatitis sifilítica: : una entidad poco frecuente

    Revista andaluza de patología digestiva, Vol. 40, Núm. 1, pp. 57-58